Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
09/08/2005 | DE102004006785A1 Verfahren zur CC-Bindungsknüpfung zwischen elektrophilen Substraten und TT-Verbindungen in neutralen bis basischen wässrigen oder alkoholischen Lösungsmitteln ohne den Einsatz einer Lewis- oder Protonensäure Process for carbon-carbon bond between electrophilic substrates and TT compounds in neutral to basic aqueous or alcoholic solvents without the use of a Lewis or protic acid |
09/07/2005 | EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
09/07/2005 | EP1571140A1 C-substituted cyclohexylmethylamine derivatives |
09/07/2005 | EP1569928A1 Therapeutic compounds and methods |
09/07/2005 | EP1569919A2 Non-nucleoside reverse transcriptase inhibitors |
09/07/2005 | EP1569895A1 Prodrugs of gaba analogs, compositions and uses thereof |
09/07/2005 | EP1495012B1 Recovery and purification of anhydro sugar alcohols from a vapor stream |
09/07/2005 | CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
09/07/2005 | CN1665798A Refreshment capable of stimulating movement of digestive tract |
09/07/2005 | CN1665773A Process for the preparation of i n /i -monosubstituted beta-amino alcohols |
09/07/2005 | CN1665503A Utilization of heteroarene carboxamide as dopamine-D3 ligands for the treatment of cns diseases |
09/07/2005 | CN1665493A Hypoglycemic agent, liver protecting agent and anticancer agent containing lignans originating in hongdoushan |
09/07/2005 | CN1663953A Process for synthesizing benzofuran and benzothiophene heterocyclic compounds |
09/07/2005 | CN1217933C Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same |
09/07/2005 | CN1217932C Antibacterial agents |
09/07/2005 | CN1217931C Spirocyclic phenyl keto-enols as pesticides and herbicides |
09/07/2005 | CN1217920C Compounds to treat Alzheimer disease |
09/06/2005 | US6939988 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them |
09/06/2005 | US6939976 reacting propene with maleic anhydride in the presence of a catalytically effective amount of an organotin chloride catalyst |
09/06/2005 | US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine, |
09/06/2005 | US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders |
09/06/2005 | US6939845 Fragrance precursors |
09/01/2005 | WO2005080371A1 Amino heterocyclic modulators of chemokine receptor activity |
09/01/2005 | WO2005080367A1 Ep2 receptor agonists |
09/01/2005 | WO2005080363A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists |
09/01/2005 | WO2005080336A1 Novel benzofurans and indols |
09/01/2005 | WO2005080322A1 Fluorene derivative |
09/01/2005 | WO2005080311A1 Hygrophorones and derivatives thereof |
09/01/2005 | WO2005080300A1 Optical resolver, process for producing optically active isomer, and 1,5-substituted bicyclo[3.3.0]-2-oxaoctane compound |
09/01/2005 | US20050192347 Urea and thiourea compounds and compositions for cholesterol management and related uses |
09/01/2005 | US20050192345 Of Monohydrate of 3-(1-(5-methylfuran-2-yl)propylamino)-4-(2-hydroxy-3-(dimethylaminocarbonyl)phenylamino)-3-cyclobutene-1,2-dione; treating pain, autoimmune diseases, cancer, transplant rejection |
09/01/2005 | US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
09/01/2005 | US20050192288 Benzofuran-2-yl-carbonyl- and indol-2-yl-carbonyl-trans-2,5-dimethyl-piperazine derivatives; rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, inflammatory bowel disease, asthma; inhibit the interaction between inflammatory chemokines and their receptor |
09/01/2005 | US20050192286 Ligands of melanocortin receptors and compositions and methods related thereto |
09/01/2005 | US20050192283 Fused-aryl and heteroaryl derivatives and methods of their use |
09/01/2005 | US20050192277 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders |
09/01/2005 | DE102004009152A1 Using ascorbic acid and its derivatives for treating teleangiektasia and vascular slackness, and for tightening superficial blood vessels |
09/01/2005 | DE102004007499A1 Verfahren zur Herstellung optisch aktiver Alkohole oder Carbonsäuren A process for producing optically active alcohols or carboxylic acids |
09/01/2005 | DE102004007498A1 Hydrierverfahren zur Herstellung optisch aktiver Alkohole oder Carbonsäuren Hydrogenation process for producing optically active alcohols or carboxylic acids |
09/01/2005 | DE102004007358A1 Kongenere, chlorierte, bromierte und/oder iodierte, fluorierte aromatische Verbindungen mit zwei Benzolringen in ihrer Grundstruktur, Verfahren zu ihrer Herstellung und ihre Verwendung Congeners chlorinated, brominated and / or iodinated, fluorinated aromatic compounds having two benzene rings in their base structure, process for their preparation and their use |
09/01/2005 | CA2556268A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists |
09/01/2005 | CA2555073A1 Amino heterocyclic modulators of chemokine receptor activity |
09/01/2005 | CA2552430A1 Novel benzofurans and indols |
09/01/2005 | CA2537079A1 Fluorene derivative |
09/01/2005 | CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production |
08/31/2005 | EP1568701A1 Transition metal complex having diphosphine complex as ligand |
08/31/2005 | EP1568690A1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers |
08/31/2005 | EP1568687A1 Sulphur-containing secondary para-Phenylenediamines, dying composition containing such para-phenylenediamines and methods using this composition and use |
08/31/2005 | EP1568367A1 Compounds effecting glucokinase |
08/31/2005 | EP1567530A1 Single pot conversion of artemisinin into arteether |
08/31/2005 | EP1567529A2 Pseudopolymorphic forms of a hiv protease inhibitor |
08/31/2005 | EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
08/31/2005 | EP1567142A2 Treatment of lung cells with histone deacetylase inhibitors |
08/31/2005 | EP1368329B1 Process for producing ascorbic acid in the presence of a sulfit |
08/31/2005 | EP1309580B1 Continuous process for the production of optically pure (s)-beta-hydroxy-gamma-butyrolactone |
08/31/2005 | EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists |
08/31/2005 | EP0989973B1 Chalcones having antiproliferative activity |
08/31/2005 | CN1662519A Heterocyclic compounds as glycine transport inhibitors |
08/31/2005 | CN1662496A Cannabinoid receptor agonists |
08/31/2005 | CN1662230A Benzoic acid derivatives as modulators of PPAR alpha and gamma |
08/31/2005 | CN1660831A New method for producing liquid tetrahydrophthalic anhydride |
08/31/2005 | CN1660830A Method for preparing ramification of monoterpenes |
08/31/2005 | CN1660829A Method for synthesizing (R)-3-amido tetrahydrofuran |
08/31/2005 | CN1660828A Method for retrieving tetrahydrofuran from waste of pharmacy |
08/31/2005 | CN1660815A Cyclic amine derivatives and their use as drugs |
08/31/2005 | CN1660741A 2-ramification of methyl alkyl diol in optical purity |
08/31/2005 | CN1660488A Preparing catalyst of tetrahydrofuran by adding hydrogen to maleic anhydride in gas phase and preparation method |
08/31/2005 | CN1660074A Crystalline composition containing escitalopram |
08/31/2005 | CN1216877C Method of preparing gamma-butyrolactone and/or 1,4-butanediol using chromium less catalyst |
08/31/2005 | CN1216876C Preparing method for tetrahydrofuran |
08/31/2005 | CN1216869C Polymorphic crystalline forms of celecoxib |
08/31/2005 | CN1216856C Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same |
08/30/2005 | US6936727 tetrahydrofuran; dicarboxylic acids, diesters, monoesters, anhydrides, lactones |
08/30/2005 | US6936722 Polyhalogenated ethers |
08/30/2005 | US6936719 pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents |
08/30/2005 | US6936638 for treating or preventing conditions associated with altered mitochondrial function with such compounds eg Alzheimer's Disease; diabetes mellitus; obesity; Parkinson's Disease; Huntington's disease; dystonia; Leber's hereditary optic neuropathy |
08/30/2005 | US6936627 treating/preventing gastrointestinal disorders, inflammations and microbial infections; improving gastroprotective properties of H2 receptor antagonists; decreasing the recurrence of ulcers; facilitating ulcer healing |
08/30/2005 | US6936610 Heterocyclic derivatives |
08/30/2005 | US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
08/30/2005 | US6936077 1,3-diamino-4-(aminomethyl)—benzene derivatives and colorants containing the said compounds |
08/25/2005 | WO2005077927A1 One pot synthesis of citalopram from 5-cyanophthalide |
08/25/2005 | WO2005077926A2 Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease |
08/25/2005 | WO2005077899A2 Amino-substituted tricyclic derivatives and methods of use |
08/25/2005 | WO2005077891A1 Method for the separation of intermediates which may be used for the preparation of escitalopram |
08/25/2005 | WO2005077871A1 Method for producing optically active alcohols or carboxylic acids |
08/25/2005 | WO2005077870A1 Hydrogenation method for producing optically active alcohols or carboxylic acids |
08/25/2005 | WO2005077868A2 Congeneric, chlorinated, brominated and/or iodised, fluorinated aromatic compounds comprising two benzol rings in their basic structure, method for their production and use thereof |
08/25/2005 | WO2005077863A1 METHOD FOR ESTABLISHING CC BONDS BETWEEN ELECTROPHILIC SUBSTRATES AND π - NUCLEOPHILES IN NEUTRAL TO ALKALINE AQUEOUS OR ALCOHOLIC SOLVENTS WITHOUT USING A LEWIS OR BRONSTED ACID |
08/25/2005 | US20050187392 Hydrolytic kinetic resolution of cyclic substrates |
08/25/2005 | US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction |
08/25/2005 | US20050187280 Furosemide modulators of HM74 |
08/25/2005 | US20050187266 2-Methyl-2-{3-[({[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]carbonyl}amino)methyl]phenoxy}propanoic acid; polycystic ovarian syndrome; polycystic obesity; dietetics; hypoglycemic agents; antilipemic and - cholesterol agents; hypertriglyceridemia; insulin resistance; metabolic disorders; PPAR modulators |
08/25/2005 | US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine |
08/25/2005 | US20050187251 Substituted N-heterocycle derivatives and methods of their use |
08/25/2005 | US20050187238 Benzofuran derivatives, their production and use |
08/25/2005 | US20050187110 Novel herbicides |
08/25/2005 | DE102004005785A1 2-Halogenfuryl/thienyl-3-carboxamide 2-Halogenfuryl / thienyl-3-carboxamides |
08/25/2005 | DE102004004901A1 Verfahren zur Herstellung von Sorbicillacton A A process for the preparation of sorbicillacton |
08/25/2005 | CA2559703A1 One pot synthesis of citalopram from 5-cyanophthalide |
08/25/2005 | CA2555884A1 Amino-substituted tricyclic derivatives and methods of use |